Genmab A (GMAB) Interest & Investment Income (2019 - 2026)

Genmab A's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $44.0 million for Q1 2026.

• Quarterly Interest & Investment Income fell 56.44% year-over-year to $44.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $710.0 million (down 19.41% YoY) and the FY2025 annual result came in at $408.0 million, down 36.74% from the prior year.
• Interest & Investment Income was $44.0 million for Q1 2026 at Genmab A, down from $312.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $328.0 million in Q3 2024 and bottomed at $44.0 million in Q1 2026.
• A 3-year average of $212.9 million and a median of $253.0 million in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2025 — Interest & Investment Income retreated 4.88% — and 2026, when it sank 56.44%.
• Genmab A's Interest & Investment Income stood at $328.0 million in 2024, then retreated by 4.88% to $312.0 million in 2025, then slumped by 85.9% to $44.0 million in 2026.
• Business Quant data shows GMAB's Interest & Investment Income at $44.0 million in Q1 2026, $312.0 million in Q3 2025, and $253.0 million in Q2 2025.